期刊文献+

通络汤对非ST段抬高性急性冠状动脉综合征患者血清超敏C-反应蛋白和脑钠肽的影响

Effect of tongluo decoction on serum levels of high sensitivity C-reactive protein and brain natri- uretic peptide in patients with non-ST segment elevation acute coronary syndrome
原文传递
导出
摘要 目的探讨通络汤对非ST段抬高性急性冠状动脉综合征血清超敏C-反应蛋白和脑钠肽的影响。方法将100例非sT段抬高性急性冠状动脉综合征患者随机分为两组,对照组40例,采用常规治疗;治疗组60例,在常规治疗的基础上加用通络汤,两组疗程均为4周。治疗前后测定血清超敏C-反应蛋白和脑钠肽,评价治疗效果。结果治疗组总疗效优于对照组(P〈0.05);两组治疗后超敏C-反应蛋白和脑钠肽均明显降低,但治疗组降低程度优于对照组(P〈0.05)。结论通络汤可通过降低血清超敏C-反应蛋白和脑钠肽水平而改善非ST段抬高性急性冠状动脉综合征患者的预后。 Objective To investigate the effect of tongluo decoction on serum levels of high sen- sitivity C-reactive protein(hs-CRP) and brain natriuretic peptide(BNP) in patients with non-ST segment elevation acute coronary syndrome(ACS). Methods One hundred patients with non-ST segment eleva- tion ACS were randomly divided into two groups, the control group (n = 40) and the treatment group (n = 60). Patients in the control group received routine treatment. Patients in the treatment group addi- tionally received tongluo decoction. The treatment course was 4 weeks in both groups. The serum levels of hs-CRP and BNP were detected before and after treatment, and the effects were evaluated. Results The serum levels of hs-CRP and BNP signiftcantly decreased in both groups, but treatment group was su- perior to control group (P 〈 0. 05). Conclusions Tongluo decoction can improve the prognosis of pa- tients with non-ST segment elevation ACS by decreasing the serum levels of hs-CRP and BNP.
作者 李继臣
出处 《中国实用医刊》 2012年第22期40-42,共3页 Chinese Journal of Practical Medicine
关键词 急性冠状动脉综合征 超敏C-反应蛋白 脑钠肽 通络汤 Acute coronary syndrome High sensitivity C-reactive protein Brain natriuretic peptide Tongluo decoction
  • 相关文献

参考文献9

  • 1Hartford M, Wiklund O, Mattsson-Hulen L, et al. Creactive protein, interlcukin-6, secretm phospholipase a group 1I A and intercdllularadhesion moleculel in the prediction of late outcome events after acute coronary syndromes [ J ]. Intern Med, 2007,262 ( 5 ) : 526 -536.
  • 2马焕云,崔忠生.冠心病患者心血管事件的危险性与hs-CRP的关系研究新进展[J].中国医师进修杂志(内科版),2007,30(8):68-69. 被引量:9
  • 3Eren NK, Ertas F, Yflksek U, et al. Additive prognostic value of NT- proBNP over TIMI risk score in intemediate-risk patients with acute coronary syndrome[ J]. Turk Kardiyol Dern Ars,2009,37 (1) :1-8.
  • 4Banach M, Markuszewski L, zaslonka J, et al. The role of innamma- tion in the pathogenesis of atherosclemsis[ J ]. Przegl Epidemio1,2004, 58(7) :663 570.
  • 5Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor[ J]. Stroke, 2001,32 ( 4 ) : 917-924.
  • 6赵晓燕,李泉生.血浆C反应蛋白与不稳定型心绞痛危险度分级关系的探讨[J].临床心血管病杂志,2003,19(5):277-279. 被引量:22
  • 7Mccullough PA, Omland T, Maisel AS. B-type natriureticpeptides:a diagnostic breakthrough for clinicans[ J]. Rev Cardiovasc Med,2003, 4(2) :72-80.
  • 8Weber M, Harem C. RoLe of B-type natriuretic peptide (BNP) and NT-pmBNP in clinical routine [ J ]. Heart, 2006,92 ( 6 ) : 843-849.
  • 9Eren NK, Ertas F, Yflksek U, et al. Additive prognostic value of NT- proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome [ J ]. Turk Kardiyol Dern Ars ,2009,37 (1) :1-8.

二级参考文献20

  • 1石文蕾,张煜,张维,宫玲,王慧婷,朱毅,郑柏生,殷民德.超敏C反应蛋白与老年冠心病严重程度的关系[J].国外医学(心血管疾病分册),2005,32(3):182-184. 被引量:17
  • 2黄玮,陈庆伟,雷寒,邓玮,柯大智.纤维蛋白原与高敏C反应蛋白对稳定性冠心病患者心血管事件的预测价值[J].中华心血管病杂志,2006,34(8):718-721. 被引量:34
  • 3[1]Ross R. Atherosclerosis--An inflammatory disease. N Engl J Med, 1999, 340:115-126.
  • 4[2]Ridker P M, Cushman M, Stampfre M J, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998, 97:425-428.
  • 5[3]Anderson J L, Carlquist J F, Joseph B, et al. Evaluation of C-reactive protein , an inflammatory marker, and infectious serology as risk factor for coronary artery disease and myocardial infarction. JACC, 1988, 32:35-35.
  • 6[4]Braunwald E. Unstable angina, a classification. Circulation, 1989, 80:410-411.
  • 7[5]Haverkate F, Thompson S G, Pyke S D M, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European concerted action on thrombosis and disabilities angina pectoris study group. Lancet, 1997, 349:462-462.
  • 8[6]Liuzzo G, Biasucci L M, Gauinore J R, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med, 1994,331:417-424.
  • 9Devaraj S,Kumaresan PR,Jialal I. Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol, 2004, 36(3) :405-410.
  • 10Wang CH,Li SH,Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation, 2003,107(13) : 1783-1790.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部